Nanjing, China, April 25-27, 2013 —
Company CEO, Dr. Haifeng Chen, chaired the Gene Therapy session and presented Virovek’s latest suicide gene therapy technology using toxins to target cancer cells at the BIT’s 4th Annual World DNA and Genome Day (WDD-2013).